Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

ClinicalTrials.gov ID: NCT07684820

Public ClinicalTrials.gov record NCT07684820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 10, 2026, 5:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants With COPD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will be randomized to receive either study drug or placebo administered once daily for 52 weeks.

Study identification

NCT ID
NCT07684820
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Expedition Therapeutics, Inc
Industry
Enrollment
600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2026
Primary completion
Jun 29, 2028
Completion
Jul 10, 2028
Last update posted
Aug 6, 2026

2026 – 2028

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
DM Clinical Research - Phoenix Phoenix Arizona 85012 Recruiting
California Medical Research Associates Inc. Northridge California 91324 Recruiting
Lynn Institute of Denver Aurora Colorado 80012 Recruiting
International Clinical Research Altamonte Springs Florida 32701 Recruiting
Nature Coast Clinical Research Crystal River Florida 34229 Recruiting
Clinical Site Partners, LLC Leesburg dba Flourish Research Leesburg Florida 34748 Recruiting
Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research Miami Florida 33135 Recruiting
Optimal Research Sites Orange Florida 32763 Recruiting
Centricity Research Columbus Rincon Georgia 31326 Not yet recruiting
DM Clinical Research-Indianapolis Indianapolis Indiana 46254 Recruiting
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 Recruiting
Headlands Research Twin Cities Maplewood Minnesota 55109 Recruiting
Carolina Research Center, Inc. Shelby North Carolina 28150 Recruiting
Remington-Davis Research Columbus Ohio 43215 Recruiting
Clinical Research Associates of Central PA, LLC DuBois Pennsylvania 15801 Recruiting
DM Clinical Research - Philadelphia Philadelphia Pennsylvania 19107 Recruiting
Horizon Clinical Research Group. Cypress Texas 77429 Recruiting
DM Clinical Research- Tomball Tomball Texas 77375 Recruiting
Burke Internal Medicine, Inc. Burke Virginia 22015 Recruiting
Tidewater Clinical Research Virginia Beach Virginia 23456 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07684820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07684820 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →